Patent · US Active

Anti-GITR antibodies

US10400040B2 · kind B2 · utility

0Cited by
6References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2017
Grant dateSep 3, 2019
Priority date—
Expiry dateAug 25, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies to human GITR are provided, as well as uses thereof, e.g., in treatment of proliferative and immune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.